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ZIKA VIRUS RNA DEGRADATION IN MUNICIPAL WASTEWATER 
 
By 
 
AARON L. MUIRHEAD 
 
 
INTRODUCTION: Zika virus (ZIKV) resurfaced in 2015 and caused a worldwide epidemic. 
ZIKV emerged as a potential cause of the serious birth defect of microcephaly, and the rare 
neurological disorder Guillain-Barre syndrome. An estimated 80% of ZIKV cases are 
asymptomatic, and treatment for the disease is not mandated until an infection of ZIKV is 
confirmed. This has caused a challenge in determining the true burden ZIKV has on 
communities that face epidemics. There has been a methodological and research gap in the 
detection and recovery of enveloped viruses, such as ZIKV, in environmental waters. Recent 
work has shown that ZIKV RNA is better detected in urine opposed to serum samples. This 
suggest that exploration of methods to understand the detectability and survivability of ZIKV in 
various waters and highlights the potential to detect it in municipal wastewater in low-resource 
settings. 
 
AIM: The objectives of this study are to develop a system for laboratory study to detect ZIKV 
RNA in environmental waters and to evaluate the stability of ZIKV RNA in sewage under three 
relevant temperatures. 
 
METHODS: ZIKV MEX 1-44 was added to primary effluent from a local municipal wastewater 
treatment plant. Two experiments were conducted. Experiment 1 was meant to assess the 
feasibility of detecting ZIKV RNA. Samples were held at 25°C and RNA was extracted at days 
0, 1, and 7. Experiment 2 consisted of samples held at 4°C, 25°C, 35°C and RNA was extracted 
at days 0, 7, 14, and 29. Quantitative polymerase chain reaction (qPCR) was used to quantify 
ZKV RNA concentration. A general linear mixed model was applied to account for repeated 
measurements and compare groups to calculate the amount of time to virus inactivation.  
 
RESULTS:  ZIKV RNA was detected in all samples at all times and temperatures with qPCR. At 
the 3 temperatures, ZIKV RNA degradation occurred over the 29 days in the 25°C and 35°C 
temperature groups and was more rapid in the 35°C group. There was little to no decrease 
observed in ZIKV RNA at 4°C.  
 
DISCUSSION: ZIKV RNA is more environmentally stable than assumed. This study was a pilot 
study to develop evidence for further exploration of materials and methods for detection of ZIKV 
RNA in wastewater. Cost-effective methods to detect ZIKV RNA in municipal wastewater such 
as this will be of crucial importance to better understand the burden ZIKV has on a community 
during epidemics due to challenges faced on detecting ZIKV infections in the clinical setting.  
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INTRODUCTION 
Zika virus (ZIKV) was first isolated in Uganda in 1947 [1], but it was not until 2007 a 
large-scale human outbreak of ZIKV was reported in Yap Island of the Federated States of 
Micronesia [2]. Outbreaks since have continued worldwide, many within the country of Brazil. 
The exact dissemination point of ZIKV human outbreaks in Brazil differs with some 
retrospective studies suggesting that ZIKV was circulating in southern Brazil from April to 
November 2013 [3-5], and others suggested the northeastern region of Brazil in February 2014 
[6]. In March 2015, Brazil reported a novel outbreak to the World Health Organization [7] with 
the initial reports stating symptoms were of a mild severity and tests were negative for 
chikungunya, measles, rubella, parvovirus B19, and enterovirus [7]. ZIKV was not suspected at 
this stage, and no tests for ZIKV were carried out. In May 2015, Brazil confirmed ZIKV virus 
was circulating in the country [7] and was also later confirmed in Bahia, Brazil by the molecular 
method of reverse transcription polymerase chain reaction (RT-PCR) [8]. Over the next two 
years ZIKV emerged as a potential cause of the serious birth defect of microcephaly, and the rare 
neurological disorder Guillain-Barre syndrome. This disease in causes the body's immune system 
to accidentally attacks part of its peripheral nervous system [9, 10]. Brazil had a notable increase 
in cases of microcephaly in newborns the summer of 2015. In late 2015, Brazil confirmed that 
the increase was associated with ZIKV that had infected pregnant women [11]. 
Similar to the dengue and chikungunya viruses, ZIKV is primarily spread by the 
mosquito Aedes aegypti, [1]. This domestic mosquito resides largely in tropical and sub-tropical 
regions. Ecological spatial analysis revealed that the northeastern region of Brazil has the highest 
risk of Aedes aegypti house infestation due to the man-made habitats best suited for larval 
development [12]. Since the initial outbreak of ZIKV in Brazil in 2015, 84 countries have 
discovered evidence of ZIKV transmission [13]. As of 2017, 23 countries have had increases of 
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Guillain-Barre syndrome and ZKV infections; and 31 countries have had an increase in 
microcephaly which was likely associated to ZIKV infection [13, 14]. Added to the current 
global impact, the effects of climate change may cause the spread of ZIKV into new 
geographical regions in the future [15].  
There has been a methodological gap in the detection and recovery of enveloped viruses 
in environmental waters. There is a long history of research that has focused on the detection and 
fate of non-enveloped enteric viruses in municipal wastewater and that they are mainly 
transmitted by the fecal-oral route (e.g., adenoviruses, polioviruses, enteroviruses, noroviruses 
and rotaviruses) [16-19]. Due to this focus, there are well-established methods for detecting non-
enveloped viruses in wastewaters. Enveloped viruses are structured differently. Enveloped 
viruses have a lipid bilayer membrane that is outside of the viral protein capsid that are not 
present in their non-enveloped counterparts. This layer has proven to impact their survival in 
aquatic environments [20, 21]. This also means that methods developed to detect non-enveloped 
viruses in wastewaters may not be ideal for detecting enveloped viruses as well. It has been 
found that common organic solvents [22] used in the concentration and purification process for 
non-enveloped enteric viruses are not suitable for enveloped viruses due to the sensitivity of the 
lipid bilayer.  
Based on the widely cited research that found ~80% of infected ZIKV patients to be 
asymptomatic [2], effective methods to detect ZIKV in sewage and environmental waters will be 
required to determine the burden on a community when it may not be properly assessed in 
resource poor settings. Currently, surveillance efforts by the Pan American Health Organization 
and World Health Organization mandate that only individuals that display ZIKV-like symptoms 
undergo laboratory testing for ZIKV infection [23]. This underestimates the true prevalence of 
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infection and related complications, leaving current estimations to be biased towards those who 
seek care or develop symptoms to an infection [24]. Due to these potential errors in determining 
true prevalence, coupled with evidence discovering that enveloped viruses are more stable in the 
environment than presumed [25], developing cost effective measures to detect ZIKV burden on a 
community has become more feasible.  
Increasing the understanding of developing a cost-effective detection method for ZIKV 
and potentially other enveloped viruses will allow resource-limited settings to assess for disease 
burden during an epidemic. This study was done with following aims: 
• To develop a system for laboratory study of ZIKV RNA in environmental waters 
• To evaluate the stability of ZIKV RNA in sewage under three relevant temperatures 
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Literature Review 
Envelope virus survival and degradation 
ZIKV’s lipid bilayer membrane outside the viral protein capsid contains glycoproteins, 
which makes it an enveloped virus [20]. The various functional groups on the outer surface of 
enveloped viruses compared to non-enveloped viruses, which does not have this outer 
membrane, likely limits enveloped virus’ survival and partitioning behavior in liquid 
environments [21, 26]. Due to this impact on the survivability, more research is needed to 
understand the ability for enveloped viruses to exist in detectable concentrations outside of their 
hosts in the environment. In recent years, this research has begun to address the ability of 
enveloped viruses to withstand environments outside of the body. A recent review noted that the 
time for 90% inactivation varied from hours to months for avian influenza (an enveloped virus) 
under relevant environmental conditions; it lasted as long as some nonenveloped viruses in 
similar conditions [27]. A study that compared the concentration value of Phi6, a commonly used 
enveloped virus surrogate, to other enveloped viruses in numerous liquid mediums highlighted 
the variability of enveloped virus’ persistence in the environment [25]. Under epidemic 
conditions, wastewater facilities must increase treatment methods to avoid transmitting 
enveloped viruses. Although treated wastewater does reduce viral load, enveloped viruses [10] 
and other infectious human viruses [28-30] have been found to be able to survive within 
wastewaters and have been detectable in wastewater treatment effluent. Also, the 2014 Ebola (an 
enveloped virus) cases in the U.S. exposed how little research has been conducted surrounding 
the presence and fate of enveloped viruses in human waste and sewage [31]. At the time, there 
were few studies that focused on the survivability of Ebola virus outside of the human body and 
few in municipal wastewater were conducted. Added to this, government agencies announced to 
the public that Ebola was not contagious outside of the body and wastewater treatment 
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procedures resulted in low risks of transmission. Since then, research has been initiated on the 
fate of Ebola virus and Ebola virus surrogates in the environment [32, 33], and research has 
found Ebola to have persisted in sterile wastewater for up to 8 days [31]. The assumption that 
Ebola rapidly inactivates outside of the human body still has not been validated. 
 
Detection of enveloped virus 
Detection of non-enveloped viruses in environmental waters has been widely studied due 
non-enveloped virus’ survivability but developing detection methods for non-enveloped and 
enveloped viruses are not same. Methods to concentrate and recover enveloped and non-
enveloped viruses differ and may not be suitable for one compared to the other. As previously 
mentioned, enveloped virus’ lipid layers are sensitive to the organic solvents (i.e. sodium 
deoxycholate, and phospholipase A.) [22] that are commonly used to extract and purify non-
enveloped enteric viruses. Recent work may have found a more suitable method by optimized 
ultrafiltration. This method yielded 18-25% recovery for two enveloped viruses in wastewater 
[10]. This research also tested a ultracentrifugation method to pellet wastewater solids, and 
concluded that the utilization of this method can effectively recover enveloped virus’ from 
wastewater for qPCR detection [10].  
Detecting ZIKV RNA in urine has increased in interest in recent years. Many studies 
describe virus detection that persists for longer durations in urine than in serum [34-38]. Work 
that compared test results for ZIKV RNA in different media found approximately twice as many 
persons with RT-PCR positive test results for ZIKV RNA in urine specimens, 61 persons (92%), 
compared with 31 persons (47%) from serum specimens respectively [39]. These studies 
reiterate that the notion that sampling urine opposed to serum can increase the number of 
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laboratory-confirmed cases in areas facing an epidemic because of a longer period of RNA 
detection, higher RNA levels, and less invasive sample collection [38]. 
In laboratory settings, the detection of ZIKV in urine can be affected by many factors 
including matrix-specific effects, handling, and storage of specimens. Little knowledge is known 
about the stability of ZIKV RNA in urine. RNA can be prone to rapid degradation in urine 
because urine is a suitable environment for a high activity of hydrolysis, up to 100 times higher 
than serum [40]. To counteract this, nucleic acid stabilizers must be used to minimize RNA 
degradation to slow the hydrolysis process and preserve the nucleic acids originally within the 
samples [41-43]. When stored at −80 °C, a common storage temperature, ZIKV RNA in urine 
samples suffered a significant loss of PCR detection without nucleic acid stabilizers [44]. At the 
same temperature, the addition of nucleic acid stabilizers to urine samples significantly corrected 
this effect and resulted in recovery of ZIKV RNA in all samples [44]. 
Wastewater epidemiology is a growing field that has had numerous studies centered on 
understanding the transmission and detection of viruses, with majority focusing on nonenveloped 
enteric viruses. With the increased interest and feasibility of studying detection of enveloped 
viruses in environmental water, employing detection methods suitable for ZIKV is a viable 
option. Considering ZKV is largely an asymptomatic disease added to the ability to detect ZKV 
in urine, this provides an opportune moment to employ research that develop detection methods 
for ZIKV which compensate for missing ZIKV cases in the clinical and expand the field of 
wastewater epidemiology. 
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Application of Multilevel modeling 
Multilevel modeling is an analytical approach that is an appropriate modeling framework 
for repeated measures data. Multilevel modeling can account for the within and between subject 
relationship for an outcome in a repeated measures setting [45]. 
With the collection of longitudinal data that is formed by repeated measurements on a 
sample or individual, a general linear mixed model is a type of multilevel model that accounts 
for within subject correlation. The within subject correlation for repeated measurements taken 
over time can be accounted for with a random effect [46]. Group effects over time can be 
compared with a group x time interaction term [46]. Mixed models that include random effects 
(random effects model) provides the opportunity to analyze the variance of the dependent 
variable based on within- and between- group components. Then, the proportion of total variance 
due to between-subject variance is quantified using the intraclass correlation coefficient (ICC) 
[47]. 
Multilevel modeling has been applied to many aspects of epidemiology (9-11) and 
sexually transmitted infections (5-8) research in recent years due to its many advantages of 
determining effects on individuals effected, the communities they are located in, and the 
geographical location of the community. In the medical field, multilevel modeling is applied to 
medical research for patients nested within a physician’s care, departments, and hospitals. 
Multilevel modeling can also be applied to microbiological experiments that have multiple 
experimental variables as well as repeated measures over time.  
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Materials and Methods 
 ZIKV MEX 1-44 was grown in mosquito cells to a concentration of 106 plaque forming 
units (pfu) per ml in the laboratory of Dr. Margo Brinton. The culture was stored at −80 °C until 
use. Primary effluent was collected from a local wastewater treatment plant in 1-liter plastic 
bottles and stored at 4ºC prior to use. The effluent was stored up to 7 days prior to inoculation 
with ZIKV.  
Controlled laboratory experiments 
We performed two laboratory experiments to examine the persistence of ZIKV RNA in 
untreated primary effluent: one at room temperature (~25℃) and one at three controlled 
temperature treatment groups: 4℃, 25℃, 35℃. In the both experiments in triplicate, we spiked 
ZIKV MEX 1-44 into each sample to achieve a concentration of 105 pfu/ml in unpasteurized 
primary effluent. In experiment 1, the ZIKV spiked samples were stored at room temperature 
~25ºC for a period of 7 days. At day 0, 1, 3, and 7, we removed aliquots and extracted nucleic 
acids. In experiment 2, the samples were stored in incubators or the refrigerator at 4 ºC, 25 ºC, 
and 35 ºC. During experiment 2, we extracted nucleic acid from the samples at days 0, 7, 14, and 
29. During both experiments, primary effluent that was not spiked with ZIKV was also incubated 
and extracted to act as a biological control.  
Nucleic acid extraction was performed using the QiaAMP Minelute Virus Spin Kit per 
kit instructions. All extractions were carried out according to the manufacturer’s 
recommendations and were eluted to a final volume of 50 μL containing Buffer AVE. All 
samples were aliquoted into duplicate samples of 25 μL and stored in -20 ºC until qPCR was 
performed. 
 Samples were tested for ZIKV RNA using one-step real-time reverse transcription 
polymerase chain reaction (RT-RNA) assay for the qualitative detection of RNA via the 
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TaqPath™ Zika Virus Kit (Fisher Scientific). RT-PCR was performed on Applied Biosystems™ 
7500 Real-Time PCR Systems Instrument and involved 25 μL reactions of the RT-PCR 
TaqPath™ Zika Virus Kit and 2.5 μL of RNA extract. Cycling conditions were based on the 
recommendations of the manufacturer and are listed in table 2.  In addition to the spiked and 
biological controls, a known concentration of ZIKV RNA was also included in the reactions to 
act as a standard curve. Each run included a negative and positive controls for ZIKV. For 
quantification, standard curves were prepared containing the target sequences with the 
assumption that the ATCC RNA standard was at 105 copy number / L.  
Data Analysis 
 For experiment 2, each replicate (A, B, C) that was in each temperature condition (4°C, 
25°C, 35°C) was extracted at 4 time points (day 0, 7, 14, 29) for a total of 36 repeated measures. 
For the statistical analysis, qPCR results from experiment 2 was used and a general linear mixed 
model applied. Treatment group of 4°C was used as the reference category in the model. Group 
by time interaction terms were included in the model to quantify comparative change. The 
intraclass correlation coefficient was calculated. Analysis was completed in SAS 9.4. 
 Data from experiment 2 were used to fit a line for each temperature in Microsoft Excel 
Version 16.6.4. The equations were then used to calculate the amount of time (days) for 
𝑙𝑜𝑔10 [
𝐶𝑡
𝐶0
] reductions to occur at 90% (-1 𝑙𝑜𝑔10 [
𝐶𝑡
𝐶0
]), 99% (-2 𝑙𝑜𝑔10 [
𝐶𝑡
𝐶0
]), 99.9% (𝑙𝑜𝑔10 [
𝐶𝑡
𝐶0
]).  
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Results 
 ZIKV RNA degradation for both experiments were assessed by qPCR. Both experiments 
differed by the temperatures the samples were exposed to. The qPCR run for experiment 1 tested 
samples that were held at a constant temperature (25°C) and had ZIKV RNA extracted on days 
0, 1, 3, and 7. Although all samples were extracted, only days 0, 1 and 7 were analyzed via qPCR 
because of time and material constraints. In experiment 2, the samples were analyzed for all 
conditions and all extractions. The qPCR run for experiment 2 tested samples that were exposed 
to three relevant temperatures (4°C, 25°C, 35°C) and had ZIKV RNA extracted on days 0, 7, 14, 
and 29.  
 The results of the initial qPCR experiment are displayed in Figure 1. As shown in figure 
1, the qPCR cycle on the X-axis and the RNA concentration on the y-axis. In addition to the 
sample replicates, the data are also provided for the standard curve. As shown by the pink, blue, 
and green lines, ZIKV RNA was detectable for all conditions initiating at cycle 18. This 
corresponds to a concentration (compared to the standard) of at least 105 RNA copies or higher. 
Also notable in figure 1, concentrations as low as 10 or 1 RNA copy were detectable via this 
assay.  
 The remaining results only displayed the calculated concentrations of ZIKV RNA copies. 
Figures 2 and 3 display the ZIKV RNA 𝑙𝑜𝑔10 concentration quantity and 𝑙𝑜𝑔10 [
𝐶𝑡
𝐶0
] of 
experiment 1 under constant temperature. Figures 3 and 4 display the ZIKV RNA 𝑙𝑜𝑔10 
concentration quantity and 𝑙𝑜𝑔10 [
𝐶𝑡
𝐶0
] of experiment 2 under the three temperatures. 
 As shown in Figures 2 and 3, the initial concentration of ZIKV RNA measured via qPCR 
assay indicated higher than inoculated concentrations (estimated to be approximately 109 copies) 
for time point 0 for rep A and B. This decreased almost three-fold on day 1 and was closer to the 
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concentration expected. This suggests that the initial concentration measurement was in error for 
day 0 for A. When comparing day 1 and day 7, ZIKV RNA concentration did not decrease 
greatly over the time when stored at room temperature (both days average concentration were 
105 copies).   
 In the second experiment, ZIKV RNA degradation demonstrated a steady decline at 
25°C, going from 105 copies on day 0 to 103 copies on week 4. At 35°C, there as a more rapid 
decline in ZIKV RNA degradation with 105 copies on day 0, to 102 copies on day 14, to the to 
101 copies at day 29. At 4°C, on average, there was a slight increase in ZIKV RNA quantity from 
baseline to slightly above baselines concentrations at day 14 in all three replicates, and 
degradation was not detected until day 29 (Figure 4 and 5).  
 
 Regression coefficients were calculated within a linear regression model with mixed 
effects. Interaction variables were added to the model to describe the comparative change in the 
response of interest for the groups. Analysis revealed that interaction variables for time x 
temperature groups 25°C and 35°C were significantly different (p < 0.05) than the time x 
temperature group at 4°C (Table 3). The ICC was calculated to describe how much the data in 
the same group resembles each other. With a low ICC of 0.112 and the value being closer to 
zero, we can conclude that data in the same groups are not similar (Table 5).  
 Regression lines were calculated in Microsoft Excel to determine 𝑙𝑜𝑔10 [
𝐶𝑡
𝐶0
] reductions 
for the three temperature groups. As shown in table 4,  the predicted values calculated from the 
regression lines to achieve 90% (−1 𝑙𝑜𝑔10), 99% (−2 𝑙𝑜𝑔10), and 99.9% (−3 𝑙𝑜𝑔10) reduction of 
ZIKV at 4°C, 25°C, and 35°C. Based on the regression line, at 4°C, it would take 123 days for a 
90% reduction, 209 days for a 99% reduction, and 295 days for 99.9% reduction for ZIKV RNA 
degradation. At 25°C, it would take 14 days for a 90% reduction, 28 days for a 99% reduction, 
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and 41 days for 99.9% reduction for ZIKV inactivation. At 35°C, it would take 6 days for a 90% 
reduction, 13 days for a 99% reduction, and 20 days for 99.9% reduction for ZIKV inactivation 
(Table 4).  
Discussion of Research Questions 
 ZIKV is a mosquito-borne enveloped virus that rapidly spread throughout the Americas 
and Caribbean in 2015. Health complications from ZIKV reached epidemic proportions in 2016. 
This lead to the WHO to declare a public health emergency of global concern in the same year 
[7]. Currently, ZIKV is primarily spread by Aedes mosquitoes, particularly Aedes aegypti and 
Aedes albopictus [48]. Recent research has created a global map of locations that are suitable for 
seasonal and year-round presence of Aedes mosquitoes, revealing that the year-round presence 
are locations closest to the Equator, and seasonal presence covering a significantly larger area 
[49]. These locations that face a year-round presence are a higher potential risk of the 
transmission of ZIKV, and may benefit the most from a cost-effective detection method of 
ZIKV. With an estimated 80% of ZIKV infections to be asymptomatic [2, 50], and symptoms 
that do appear are similar to many other diseases [51], other detection methods must be 
implemented in settings that face ZIKV endemics.  
 The diagnosis of ZIKV infection has relied heavily on the detection of ZIKV RNA or 
ZIKV antibodies in serum (mostly in the clinical setting). This route has been found to be 
challenging, with the detection duration of ZIKV in serum to be short lived and the possibility of 
cross reactivity of ZIKV antibodies to other diseases such as dengue virus. Many reports have 
shown that the detection of ZIKV in urine is longer than serum [34-38]. Little to no research has 
performed on the survivability of ZIKV in waters or wastewater. Wastewater epidemiology is a 
growing field, and this study adds to our understanding the potential to detect ZIKV in 
wastewater. Similar to the work of Ye et al. that used model enveloped viruses, this study was 
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able to detect ZIKV RNA, an enveloped virus, in spiked, untreated wastewater over weeks at 
various conditions. A recent meta-analysis has found that envelope viruses can take hours and up 
to weeks for a 90% virus reduction to occur in relevant environmental conditions [25].  
 In this study, there was a detected increase in ZIKV RNA concentration within each 
replicate at 4°C at time point 0 and 7 until day 14 in Experiment 2. There was an approximate 
10-fold higher concentration in the samples held at 4°C compared to 25°C. Similar results were 
found when ZIKV RNA concentration was quantified to understand ZIKV stability in urine. 
Within the first 48 hours, while stored at 4°C, there was little decrease in ZIKV RNA 
concentration and concentrations were higher at each time point compared to samples held at 
25°C [44].   
Study Strengths and Limitations 
 The strengths of this study include the use of unpasteurized primary effluent and multiple 
temperatures. This is the first study to evaluate the persistence of ZIKV RNA outside of the 
clinical conditions and setting. We document ZIKV RNA persistence for weeks at high 
temperatures suggesting that the ZIKV may be detectable under environmental conditions found 
in many endemic settings.  
            The results of this study adds to the growing field of wastewater epidemiology. The 
assumption that enveloped viruses rapidly inactivate outside of the human body and in aqueous 
environment continues are in contrast with our findings. Utilizing wastewater samples can also 
be a valuable alternative or addition to ZIKV infection data collected in the clinical setting.   
            There are three main limitations of this study. First, the unpastuerized wastewater was not 
sourced from a location that has been exposed to a known ZIKV endemic. Second, the results of 
this study cannot conclude that the detection of ZIKV RNA is associated with infectivity of 
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ZIKV. Third, the quantification of ZIKV RNA concentration using qPCR is not the most ideal 
method of quantification as the intention of the kit was for qualitative detection.   
Recommendations of Future Findings 
Future work can be done to further document the ZIKV infectivity to determine if the virus is 
intact or if only the RNA persisted. This can also inform collection of wastewater samples to 
further the knowledge on the detection and survivability of enveloped viruses for the field of 
wastewater epidemiology. The application of this procedure with sewage samples from endemic 
areas can be an area of future research for research and clinical purposes. Research can also 
focus on the likelihood of infectivity of ZIKV from the detection of ZIKV RNA.  
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 Table 1. Sample conditions for RNA extraction. 
Experiment Temperature Replicate Time of Extractions 
(days) 
1 ~25°C A, B, C 0, 1, 3, 7 
2 4°C 
25°C 
35°C 
A, B, C 
A, B, C 
A, B, C 
0, 7, 14, 29 
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Table 2. Details of the steps and thermal cycling conditions of the samples during qPCR. 
Steps Thermal Cycling Conditions 
Transcription HOLD 50°C for 10 min 
Activation HOLD 95°C for 2 min 
PCR Amplification 40 cycles 95°C for 3 sec 
60°C for 30 sec 
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Table 3. Parameter estimates for the general linear mixed model (*p<0.05)_ 
Effect Temp Estimate (95% CI) DF p-value 
Intercept - 0.3444 (-0.7732, 1.4621) 2 0.316 
Time - -0.0079 (-0.03728, 0.02132) 28 0.5814 
Temp 4°C 0 Ref Ref 
Temp 25°C -0.3441 (-1.027, 0.3387) 28 0.3108 
Temp 35°C -0.6754 (-1.3583, 0.0075) 28 0.0524 
Time*Temp 4°C 0 Ref Ref 
Time*Temp 25°C -0.0657 (-0.1072, -0.02428) 28 0.003* 
Time*Temp 35°C -0.1554 (-0.1968, -0.1139) 28 <.0001* 
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Table 4. Predicted times (in days) for 𝑙𝑜𝑔10 reductions for virus inactivation at three temperature 
groups 
 
Temp Reduction 𝑙𝑜𝑔10 [
𝐶𝑡
𝐶0
] Time* (days) 
 
4°C 
-1 (90%) 123 
-2 (99%) 209 
-3 (99.9%) 295 
 
25°C 
-1 (90%) 14 
-2 (99%) 28 
-3 (99.9%) 41 
 
35°C 
-1 (90%) 6 
-2 (99%) 13 
-3 (99.9%) 20 
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Table 5. Variance Estimates and Intracluster Correlation Coefficient 
Variance Estimates 
Covariance Parameters Subject Estimate 
Intercept Replicate 0.03572 
Residual --- 0.283 
𝐸𝑠𝑡𝑖𝑚𝑎𝑡𝑒 𝑜𝑓 𝐼𝐶𝐶 =
0.03572
0.03572 + 0.283
= 0.112 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 32 
Figure 1: qPCR results for the detection of ZIKV RNA from spiked sewage that was held at 
25°C and extracted at day 0, 1 and 7. 
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Figure 2. 𝑙𝑜𝑔10 concentration values of ZIKV RNA degradation at constant temperature of 25°C 
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Figure 3. 𝑙𝑜𝑔10 [
𝐶𝑡
𝐶0
] values of ZIKV RNA degradation at constant temperature of 25°C 
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Figure 4. 𝑙𝑜𝑔10 concentration values of ZIKV RNA degradation at various temperatures of 4°C, 
25°C, 35°C 
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Figure 5. 𝑙𝑜𝑔10 [
𝐶𝑡
𝐶0
] values of ZIKV RNA degradation at various temperatures of 4°C, 25°C, 
35°C 
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Appendix 
SAS 9.4 Input Code for Mixed Model Analysis 
 
data thesis2; 
input temp $ time rep $ y; 
datalines; 
4 0 A 0 
4 7 A 0.575641 
4 14 A 0.751433 
4 29 A -0.19964 
4 0 B 0 
4 7 B 0.502817 
4 14 B 0.537913 
4 29 B -0.15201 
4 0 C 0 
4 7 C 0.413423 
4 14 C 0.487973 
4 29 C 0.018496 
25 0 A 0 
25 7 A -0.47481 
25 14 A -0.91801 
25 29 A -2.13049 
25 0 B 0 
25 7 B -0.41935 
25 14 B -0.85398 
25 29 B -2.01454 
25 0 C 0 
25 7 C -0.70911 
25 14 C -1.23836 
25 29 C -2.29359 
35 0 A 0 
35 7 A -1.46241 
35 14 A -2.07631 
35 29 A -4.22073 
35 0 B 0 
35 7 B -0.55926 
35 14 B -3.2746 
35 29 B -4.65993 
35 0 C 0 
35 7 C -2.13746 
35 14 C -4.81133 
35 29 C -5.27542 
 
; 
run; 
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proc mixed data=thesis2; 
class temp rep ; 
model y = time temp time*temp / s CL; 
random intercept / subject = rep s; 
run; 
 
 
 
